Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kazia Therapeutics Ltd (NASDAQ:KZIA)

3.20
Delayed Data
As of Nov 24
 0.00 / 0.00%
Today’s Change
1.63
Today|||52-Week Range
7.60
-45.41%
Year-to-Date
No recent news for Kazia Therapeutics Ltd.

Today’s Trading

Previous close3.20
Today’s open3.20
Day’s range3.20 - 3.20
Volume2,454
Average volume (3 months)7,575
Market cap$15.3M
Dividend yield--
Data as of 12:02pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)+79.05%
Earnings growth (this year)-58.23%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.23

Competitors

 Today’s
change
Today’s
% change
CBIOCatalyst Biosciences...0.000.00%
ABIOARCA Biopharma Inc0.000.00%
OGENOragenics Inc0.000.00%
ONTXOnconova Therapeutic...0.000.00%
Data as of 4:00pm ET, 11/24/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Director-Finance &
Administration
Gabrielle Heaton
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts